Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New software improves Danish X-ray throughput:

This article was originally published in Clinica

Executive Summary

The Danish county councils are pressing ahead with measures to revolutionise the use of IT in the health service, despite the reluctance of doctors to use computers. Despite the introduction of the electronic patient journal, many doctors prefer to dictate information to secretaries, who then type this into the computer. The Velje-Give Hospital has now been given speech recognition software to overcome this problem. The equipment has currently been installed in the X-ray department in Velje and it is also due to be introduced at the pathology institute. Not only does it free up hospital staff, but it also means that descriptions of X-ray images, which used to take up to two days, can now be completed within an hour, said Johannes Gaub, senior physician at the Velje-Give Hospital.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT063404

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel